Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout. [PDF]
Richette P +13 more
europepmc +1 more source
Clinical response to firsekibart in a 73-year-old patient with tophaceous gout complicated by prostate cancer and chronic kidney disease: a case report. [PDF]
Li Z, Jie Y, Zhou Y, Li Y.
europepmc +1 more source
Effects of adding urinary alkalizer citrate mixture to febuxostat in gout patients with combined-type hyperuricemia and low urine pH: a prospective cohort study. [PDF]
Guo K +17 more
europepmc +1 more source
Hepatic Safety of Febuxostat and Allopurinol in Gout Patients: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]
Dewi C +5 more
europepmc +1 more source
Formulation, characterization and evaluation of cytotoxic potential for febuxostat loaded chitosomes against cervical cancer cells (Hela cells). [PDF]
Sakran W +2 more
europepmc +1 more source
Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadeninuria. [PDF]
Edvardsson VO +2 more
europepmc +1 more source
An uncommon encounter with tumor lysis syndrome in colorectal cancer. [PDF]
de Matos UMA +7 more
europepmc +1 more source
Pediatric hyperuricemia: genetic basis, metabolic mechanisms, and clinical implications. [PDF]
Zhou J +6 more
europepmc +1 more source
Allopurinol-Induced Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: A Case Report and Review of the Published Evidence From India. [PDF]
Shinde A +4 more
europepmc +1 more source
Efficacy and safety of urate-lowering therapies in asymptomatic hyperuricaemia: a systematic review and network meta-analysis of key clinical outcomes. [PDF]
Yi Y, Yang J, Chen Y, Liu H, Deng Y.
europepmc +1 more source

